Biomedical Engineering Reference
In-Depth Information
124. H.Ringsdorf, Structure and properties of pharmacologically active
polymers,
J.polym.Sci
.Polym.Symp 51(1975) 135-153.
125. Jae Hyung Park, Gurusamy Sarvanakumar, Kwangmeyung Kim, Ick Chan
Kwon.Targeted delivery of low molecular drugs using chitosan and its deriv-
atives.
Advanced drug delivery reviews
62 (2010) 28-41.
126. Y.J.Son, J.S.Jang, Y.W.Cho,. H.Chung, R W. Park, I.C.Kwon, I.S.Kim, J.Y.Park,
S.B.Seo,C.R. Park, S.Y.Jeong. Biodistribution and anti-tumor ei cacy of
doxorubicin loaded glycol-chitosan nanoaggregates by EPR ef ect,
J.Control
Release
91(2003) 135-145.
127. Y.Ohya, M.Shiratani, H.Kobayashi,T Ouchi, Release behaviour of 5-l uoro-
uracil from chitosan-gel nanospheres immobilizing 5-l uorouracil coated
with polysaccharides and their cell specii c cytotoxicity,
Pure Appl.Chem
A31(1994) 629-642.
128. Q.A.Pankhurst, J.Connolly, S.K.Jones, J.Dobson.Applications of magnetic
nanoparticles in biomedicines,
J.Phys D:Appl. Phys.
36(2003) R167-R181.
129. L. Zhou J.Ma, N, Jia, Y. Zhao, H Shen. Chitosan-coated magnetic nanopar-
ticles as carriers of 5-l uorouracil preparation, characterization and cytotox-
icity studies, colloids. Surf B,
Biointerfaces
, 68(2009), 1-6.
130. Y.C.Chang, D.B.Shieh, C.H.Chang, D.H. Chen, Conjugation of monodis-
perse chitosan-bound magnetic nanocarrier with epirubicin for targeted
cancer therapy,
J.Biomed.Nanotech
1 (2005) 196-201.
131. Liu Q, Zhang J, Xia W, Gu H. Magnetic i eld enhanced cell uptake ei -
ciency of magnetic silica mesoporous nanoparticles.
Nanoscale
, 2012 Jun
7,4(11):3415-3421.
132. Nikola Z.Knezevic and Victor S.Y.Lin.Amagnetic mesoporous silica
nanoparticle-based drug delivery system for photosensitive cooperative
treatment of cancer with a mesopore-capping agent and mesopore-loaded
drug.
Nanoscale
,2013,5, 1544-1551
133. Sahoo SK, Ma W, Labhasetwar V.Ei ciency of transferring-conjugated pacli-
taxel nanoparticles in a murine model of prostrate cancer.
Int J Cancer
,2004,
Nov 1;112(2):335-40.
134. Videira MA, Botelho MF, Santos AC, Gouveia LF, de Lima JJ, Almeida
AJ.Lymphatic uptake of pulmonary delivered radiolabelled solid lipid
nanoparticles. J.Drug Target,2002,Dec;10(8):607-13.
135. Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R.
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate
cancer cells.
Cancer Res.
2004 Nov 1:64(21): 7668-72.
136. Md.Nurunnabi,Zehedina Khatun, Woo-Choon Moon, Gibaek Lee, Yong-
Kyu Lee. Heparin based nanoparticles for cancer targeting and non-invasive.
Research highlight
, 7, 2012.
137. Juqun Xi, Jin Qin, Lei Fan. Chondriotin sulphate functionalized meso-
structured silica nanoparticles as biocompatible carriers for drug delivery.
International Journal of Nanomedicine
oct 2012.
138. Li Deng, Xingfa Ke, Zhiying He, Daoqiu Yangs, Hai Gongs, Yingying
Zhang, Xiaolong Jing, Jianzhong Yao, Jianming Chen. A MSLN-targeted
